Histoplasmosis & Blastomycosis for MRCP Part 1
top of page
Search

Histoplasmosis & Blastomycosis for MRCP Part 1

TL;DR

Systemic Mycoses: Histoplasmosis/Blastomycosis is a high-yield infectious diseases topic for MRCP Part 1, particularly in questions involving travel history, immunocompromise, granulomatous lung disease and fungal diagnostics. Histoplasmosis commonly mimics tuberculosis, whereas blastomycosis is more associated with cutaneous and osteoarticular dissemination. Candidates should know the hallmark microscopy findings, common epidemiological clues and first-line antifungal treatment strategies.


Why this matters

Systemic fungal infections are relatively uncommon in UK clinical practice, but they are disproportionately represented in postgraduate examinations because they combine microbiology, respiratory medicine, infectious diseases and immunology in a single clinical scenario.

In MRCP Part 1, questions on histoplasmosis and blastomycosis often test:

  • Recognition of travel-associated infections

  • Opportunistic infections in HIV

  • Interpretation of fungal microscopy

  • Differential diagnosis of granulomatous lung disease

  • Appropriate antifungal therapy

For a broader revision framework, review the <a href="https://www.crackmedicine.com/ Part 1 overview</a> and practise exam-style questions in the <a href=https://www.crackmedicine.com/qbankMRCP MCQs</a> section.


Histoplasmosis: High-Yield MRCP Facts

Organism

Histoplasmosis is caused by Histoplasma capsulatum, a dimorphic fungus.

Key microbiology point

  • Mould in the environment

  • Yeast in human tissue

Dimorphism is a favourite MRCP microbiology concept.

Epidemiology

The classic epidemiological associations are:

  1. Ohio and Mississippi River valleys

  2. Central and South America

  3. Exposure to bat droppings

  4. Bird guano exposure

  5. Cave exploration

  6. Old barns or chicken coops

Travel history is commonly embedded in MRCP stems.

Classic exam clue

“A patient develops fever and pulmonary symptoms after cave exploration.”

This should immediately suggest histoplasmosis.

Clinical manifestations

Most infections are asymptomatic. Symptomatic disease can present in several forms.

Clinical syndrome

Key features

Acute pulmonary histoplasmosis

Fever, dry cough, chest pain

Chronic pulmonary histoplasmosis

Cavitary upper lobe disease resembling TB

Disseminated histoplasmosis

Fever, hepatosplenomegaly, pancytopenia

CNS histoplasmosis

Chronic meningitis

Mediastinal fibrosis

Compression syndromes


Pulmonary histoplasmosis

Pulmonary disease is the most frequently tested form.

Typical findings

  • Fever

  • Malaise

  • Non-productive cough

  • Bilateral hilar lymphadenopathy

  • Diffuse reticulonodular infiltrates

Important MRCP point

Histoplasmosis is a classic mimic of tuberculosis.

Both conditions may produce:

  • Weight loss

  • Chronic cough

  • Cavitary lung lesions

  • Granulomatous inflammation

Candidates should consider fungal infection when tuberculosis investigations are negative.

Disseminated histoplasmosis

Disseminated disease is particularly important in immunocompromised patients.

High-risk groups

  • Advanced HIV/AIDS

  • Organ transplant recipients

  • Patients receiving TNF-alpha inhibitors

  • Long-term corticosteroid therapy

Key features

  • Fever

  • Hepatosplenomegaly

  • Pancytopenia

  • Oral ulcers

  • Adrenal involvement

The MRCP exam frequently tests disseminated histoplasmosis in advanced HIV infection.


Diagnosis of histoplasmosis

Key diagnostic methods

  • Urine Histoplasma antigen

  • Fungal culture

  • Tissue biopsy

  • Serology

  • Histopathology

Classic microscopy finding

Small intracellular yeast forms within macrophages

This is one of the highest-yield fungal microscopy facts for MRCP.

Treatment of histoplasmosis

Severity

Treatment

Mild pulmonary disease

Often supportive

Moderate disease

Itraconazole

Severe disseminated disease

Liposomal amphotericin B followed by itraconazole

Important exam principle

  • Severe fungal disease → amphotericin B

  • Stable disease → itraconazole


Blastomycosis: High-Yield MRCP Facts

Organism

Blastomycosis is caused by Blastomyces dermatitidis, another dimorphic fungus.

Epidemiology

Blastomycosis is associated with:

  • North America

  • Great Lakes region

  • Mississippi River basin

  • Decaying wood and soil exposure

The geographical overlap with histoplasmosis can create exam traps.

Clinical manifestations

Pulmonary blastomycosis

Common symptoms include:

  • Fever

  • Productive cough

  • Weight loss

  • Haemoptysis

Radiological appearances may mimic:

  • Bacterial pneumonia

  • Lung carcinoma

  • Tuberculosis

Extrapulmonary dissemination

Blastomycosis is especially notable for skin and bone involvement.

Common sites

  • Skin

  • Bone

  • Genitourinary tract

  • CNS

Characteristic skin lesions

  • Verrucous plaques

  • Ulcerative lesions

This is an important differentiator from histoplasmosis.

Diagnosis of blastomycosis

Hallmark microscopy finding

Broad-based budding yeast

This is the single most important blastomycosis fact for MRCP candidates.

Diagnostic tools

  • Fungal culture

  • Histopathology

  • Bronchoalveolar lavage

  • Tissue biopsy

Treatment of blastomycosis

Severity

Treatment

Mild/moderate disease

Itraconazole

Severe or CNS disease

Liposomal amphotericin B

Again, amphotericin B is reserved for severe disease.


Five Most Tested Subtopics

1. Dimorphic fungi

Both Histoplasma and Blastomyces are dimorphic:

  • Mould in the environment

  • Yeast in tissue

This is repeatedly tested in fungal infection questions.

2. Tuberculosis mimicry

Histoplasmosis particularly resembles pulmonary TB.

Shared features include:

  • Cavitation

  • Weight loss

  • Chronic cough

  • Granulomatous inflammation

3. Opportunistic infection in HIV

Disseminated histoplasmosis is highly associated with advanced HIV infection.

Candidates should recognise:

  • Fever

  • Pancytopenia

  • Hepatosplenomegaly

  • Intracellular yeast

4. Microscopy clues

Fungus

Hallmark finding

Histoplasma

Intracellular yeast in macrophages

Blastomyces

Broad-based budding yeast

Memorising these descriptions secures easy microbiology marks.

5. Antifungal therapy

High-yield principle

  • Itraconazole → stable disease

  • Amphotericin B → severe disease

This treatment pattern appears repeatedly across fungal infection questions.


Practical examples / mini-cases

Mini-case MCQ

A 42-year-old man presents with fever, weight loss and chronic cough after returning from cave exploration in the United States. Chest imaging demonstrates bilateral hilar lymphadenopathy. HIV testing is positive with a CD4 count of 40 cells/µL. Bone marrow biopsy demonstrates intracellular yeast forms within macrophages.

What is the most likely diagnosis?

A. BlastomycosisB. HistoplasmosisC. CryptococcosisD. AspergillosisE. Coccidioidomycosis

Answer

B. Histoplasmosis

Explanation

This is a classic presentation of disseminated histoplasmosis:

  • Cave exposure

  • Advanced HIV infection

  • Reticuloendothelial involvement

  • Intracellular yeast within macrophages

Blastomycosis would more classically demonstrate broad-based budding yeast and prominent cutaneous involvement.

To practise similar infectious diseases questions, visit the <a href=https://www.crackmedicine.com/mock-tests start a mock test</a> section or revise systematically through the <a href=https://www.crackmedicine.com/lectures library</a>.


Practical study-tip checklist

Histoplasmosis checklist

  • Memorise bat and bird exposure

  • Recognise intracellular yeast in macrophages

  • Remember TB mimicry

  • Know disseminated disease in HIV

  • Recall itraconazole as standard oral therapy

Blastomycosis checklist

  • Memorise broad-based budding yeast

  • Recognise skin and bone dissemination

  • Know pulmonary mimicry of malignancy

  • Remember North American epidemiology

  • Use amphotericin B for severe disease

Exam preparation materials for MRCP Part 1 infectious diseases revision

Common pitfalls

  • Confusing histoplasmosis with pulmonary tuberculosis

  • Forgetting that both organisms are dimorphic fungi

  • Missing disseminated histoplasmosis in HIV patients

  • Confusing broad-based budding with narrow-based budding yeast

  • Incorrectly choosing fluconazole instead of itraconazole


Revision strategy for MRCP Part 1

Systemic fungal infections are best approached through pattern recognition rather than rote memorisation.

Effective revision approach

  1. Learn geographical associations

  2. Memorise hallmark microscopy findings

  3. Compare pulmonary versus disseminated disease

  4. Focus on immunocompromised hosts

  5. Revise antifungal therapy principles

A useful linked revision topic is opportunistic infections in immunocompromised patients, particularly HIV-related fungal disease.

Additional MRCP preparation resources:


FAQs

Is histoplasmosis commonly tested in MRCP Part 1?

Yes. Histoplasmosis is a classic exam topic because it combines infectious diseases, respiratory medicine, HIV medicine and travel history interpretation.

What is the hallmark finding in blastomycosis?

Blastomycosis classically demonstrates broad-based budding yeast on microscopy.

Which antifungal is most important for MRCP fungal questions?

Itraconazole is the key oral antifungal for histoplasmosis and blastomycosis, while amphotericin B is reserved for severe disease.

Why does histoplasmosis mimic tuberculosis?

Both diseases may produce chronic cough, weight loss, cavitary upper lobe disease and granulomatous inflammation.

Which patients are at highest risk of disseminated histoplasmosis?

Patients with advanced HIV infection, transplant recipients and those receiving significant immunosuppressive therapy are at highest risk.


Ready to start?

Strengthen your preparation with structured revision via the MRCP Part 1 overview. Practise actively using the Free MRCP MCQs and simulate exam conditions with a Start a mock test.

For deeper understanding, combine this guide with lecture-based revision at:https://www.crackmedicine.com/lectures/


Sources

  1. MRCP(UK) Examination Blueprint — https://www.mrcpuk.org/mrcpuk-examinations/part-1-examination

  2. CDC Histoplasmosis Resource — https://www.cdc.gov/fungal/diseases/histoplasmosis/index.html

  3. CDC Blastomycosis Resource — https://www.cdc.gov/fungal/diseases/blastomycosis/index.html

  4. European Confederation of Medical Mycology — https://www.ecmm.info/guidelines/

  5. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases

  6. British Infection Association — https://www.britishinfection.org/

 
 
 
bottom of page